The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectives.
about
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Molecular docking as a popular tool in drug design, an in silico travelA cross sectional study of knowledge and attitudes towards tuberculosis amongst front-line tuberculosis personnel in high burden areas of Lima, PeruReduction of maternal mortality with highly active antiretroviral therapy in a large cohort of HIV-infected pregnant women in Malawi and MozambiqueEmerging and Neglected Infectious Diseases: Insights, Advances, and Challenges.Vaccines for all: Institut Pasteur vaccinology course, 2010.Muslim women's reflections on the acceptability of vaginal microbicidal products to prevent HIV infection.Toward a consensus on guiding principles for health systems strengthening.Evaluations of training programs to improve human resource capacity for HIV, malaria, and TB control: a systematic scoping review of methods applied and outcomes assessed.Importance of nonenteric protozoan infections in immunocompromised people.A multiplex assay for the simultaneous detection of antibodies against 15 Plasmodium falciparum and Anopheles gambiae saliva antigens.In vivo persistence and protective efficacy of the bacille Calmette Guerin vaccine overexpressing the HspX latency antigen.Tuberculosis mortality in HIV-infected individuals: a cross-national systematic assessmentStructure of the essential Plasmodium host cell traversal protein SPECT1.Untreated pain, narcotics regulation, and global health ideologiesFactors that influence utilisation of HIV/AIDS prevention methods among university students residing at a selected university campus.Prediction of the interaction of HIV-1 integrase and its dicaffeoylquinic acid inhibitor through molecular modeling approach"Every drug goes to treat its own disease…" - a qualitative study of perceptions and experiences of taking anti-retrovirals concomitantly with anti-malarials among those affected by HIV and malaria in Tanzania.Dynamics of the major histocompatibility complex class I processing and presentation pathway in the course of malaria parasite development in human hepatocytes: implications for vaccine development.Natural antibody response to Plasmodium falciparum merozoite antigens MSP5, MSP9 and EBA175 is associated to clinical protection in the Brazilian Amazon.Malaria incidence from 2005-2013 and its associations with meteorological factors in Guangdong, China.One nanoprobe, two pathogens: gold nanoprobes multiplexing for point-of-care.Suboptimal patterns of provider initiated HIV testing and counselling, antiretroviral therapy eligibility assessment and referral in primary health clinic attendees in Blantyre, Malawi.Laboratory system strengthening and quality improvement in EthiopiaPerformance evaluation of the MBio Diagnostics point-of-care CD4 counter.A public health approach to global management of hypertensionTrend of Smear-positive Pulmonary Tuberculosis in Iran during 1995-2012: A Segmented Regression Model.Potential impact of the US President's Emergency Plan for AIDS relief on the tuberculosis/HIV coepidemic in selected Sub-Saharan African countries.Validation of ELISA for quantitation of artemisinin-based antimalarial drugs.The antimalarial drug quinine interferes with serotonin biosynthesis and action.White Matter Microstructural Integrity and Neurobehavioral Outcome of HIV-Exposed Uninfected Neonates.Evaluating the utility of provider-recorded clinical status in the medical records of HIV-positive adults in a limited-resource setting.External quality assessment in resource-limited countries.CPP-ZFN: a potential DNA-targeting anti-malarial drug.Drug repositioning in the treatment of malaria and TB.Emerging drugs for malaria.Actionable theranostics for global maternal health: a focus on HIV and malaria.Strategies for overcoming challenges for decentralised diagnostics in resource-limited and catastrophe settings.Implementing Global Fund programs: a survey of opinions and experiences of the Principal Recipients across 69 countries.Optimization of Compound Plate Preparation to Address Precipitation Issue in Mammalian A549 Cytotoxicity Assay.
P2860
Q21034169-9ECA3C77-FD90-48AC-8BAD-A874AA024A2CQ26743663-9C07D810-AE7A-43A5-8D1E-16805C505C98Q28533646-363E0163-8802-44BC-AB70-E8C97DEBE51CQ28535436-269CA344-E1E6-4939-959F-6ECA5B05F62EQ30235317-166CA6E8-E237-4C12-88BE-2D5E999543DEQ30393369-752CA1F5-AEC3-4F5D-BD89-1503FE04746EQ30399805-183E5A4F-6EE3-4F04-B4B9-7228F1DFDA0EQ33784895-0C0E63C5-3783-4966-9C67-1C600FC8B746Q33861824-7CB3AB25-81AB-4C8C-82BA-DE3EA1DBAC2EQ34189873-AC0B74BF-2D8F-4704-82D7-D96D08B2C176Q34351117-EEA5FDA1-9ABE-41B8-A878-D59654B6DE8DQ34558242-103E9BD2-6D0D-46EB-9FF4-8E7DDF9066F1Q34560360-7760823E-9DBE-4CD8-9F63-CE831D80B2E2Q34640843-264AF911-59DA-4C9C-BB46-1638145A7EB4Q34657813-0BB1F5F0-E8AB-4ECA-B045-2E2A09530E1AQ34743612-6DC934A8-DD09-4793-A31A-84DE8D41926EQ34952453-271FB207-F8AD-4C28-ACDA-F22A40598554Q34996394-83E7F194-2E5F-4838-9252-164ACD02F0B4Q35005560-9B00C462-F1FA-468E-A5B0-FD1FDE20D0A1Q35076906-5D6F37B0-F83C-4B5E-818D-5E2C6627CE60Q35312719-55A0309E-33DD-4008-B8DB-AB9635531DBEQ35922933-84038252-5EB8-4BB6-992D-DAA041F74E6BQ36043429-9D41133B-8761-49F5-83CD-29BA0D17B703Q36435759-1E02AE34-4327-4CC5-B28A-FB0402C4C11BQ36487333-D1D270AA-BFB5-475B-85BC-54057CAFD64DQ36794286-D09D8615-D476-46EC-91C6-D46E7EB8DB65Q37051009-DA3875AD-2C3F-4C36-B739-4FF8FAB510D7Q37332200-3A7AD277-B2D3-4EC6-A699-5E1921EEE646Q37372616-414C1080-2CA7-4638-80DD-680F9B8DF1C3Q37453950-EFACF83E-CAD3-48E1-97F5-C5CCA82D4172Q37624090-9C3C17A8-41BC-4270-A2D0-5CF1BD861CCCQ37625173-B2F7CBB5-956D-4718-A512-834AA60A1DE0Q37739778-6AC05CC1-9BE9-4952-83E7-5236F11C4BA5Q37789464-49114BCB-600F-4F67-A0ED-4134FC0C0DF5Q37924298-4CA42310-1C9F-4003-BEC1-EE8D0166188CQ38027179-5BBE6655-DE13-4153-ABA7-5614D88B8B71Q38068222-871CD5DC-C298-4259-9352-4EB4101B3446Q38374666-79B759B2-B0BB-4027-BD40-229CFE15E8F2Q38768469-161F02AE-343C-450E-9F2D-BA28EA5E15A4Q38851873-19F4754B-534E-4673-B0C5-6786C6120F85
P2860
The global fight against HIV/AIDS, tuberculosis, and malaria: current status and future perspectives.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The global fight against HIV/A ...... tatus and future perspectives.
@en
The global fight against HIV/A ...... tatus and future perspectives.
@nl
type
label
The global fight against HIV/A ...... tatus and future perspectives.
@en
The global fight against HIV/A ...... tatus and future perspectives.
@nl
prefLabel
The global fight against HIV/A ...... tatus and future perspectives.
@en
The global fight against HIV/A ...... tatus and future perspectives.
@nl
P2093
P921
P356
P1476
The global fight against HIV/A ...... tatus and future perspectives.
@en
P2093
Christian Gunneberg
Kevin M De Cock
Marco Vitoria
Mehran Hosseini
Reuben Granich
Wilson Were
P304
P356
10.1309/AJCP5XHDB1PNAEYT
P407
P577
2009-06-01T00:00:00Z